本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Design Therapeutics, Inc.

5.53
-0.1100-1.95%
成交量:22.41万
成交额:123.42万
市值:3.15亿
市盈率:-4.94
高:5.65
开:5.65
低:5.24
收:5.64
52周最高:7.77
52周最低:2.60
股本:5,694.81万
流通股本:2,627.76万
量比:1.19
换手率:0.85%
股息:- -
股息率:- -
每股收益(TTM):-1.1191
每股收益(LYR):-0.8763
净资产收益率:-26.77%
总资产收益率:-19.02%
市净率:1.48
市盈率(LYR):-6.31

数据加载中...

2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/08/26

重要事件披露

Form 8-K - Current report
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/14

重要事件披露

8-K - Current report
2023/03/14

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals